Writer and featured expert

Jessica and her views on science, global health, and careers have been featured through a number of outlets, including the American Society of Tropical Medicine and Hygiene, Global Network for Neglected Tropical Diseases, PLoS Blogs, and Global Health Now.

Academic Publications/Technical Reports

  • Taaffe, J. et al. (2021) Advancing tuberculosis research using digitized programmatic data. IJTLD.

  • Wollenberg, K. et al. (2020) A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status. BMC Infect Dis.

  • Raja, A., Brickley, E., Taaffe, J. et al (2019) A primate model of severe malarial anemia: a comparative pathogenesis study. Sci Rep.

  • Rosenthal, A., et al (2017) The TB Portals: An Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis, J Clin Microbio.

  • Taaffe, J., and Wilson, D (2017) “Tailoring the local HIV response to local HIV epidemics”, Disease Control Priorities, 3rd Ed.: Major Infectious Diseases.

  • Taaffe, J., Longosz, A., and Wilson, D. (2017) The impact of cash transfers on livelihoods, education, health and HIV – what's the evidence? Dev Policy Rev.

  • Bali, S., and Taaffe, J. (2017) Exploring the synergies between the SDGs and Global Health Security Agenda for a sustainable and resilient world. J of Public Health Policy

  • Taaffe, J., and Wilson, D. (2016) Mobilizing a Global Movement for Hepatitis: Lessons Learned from the HIV Response. Global Public Health, 1-16.

  • Taaffe J, Cheikh N, Wilson D. (2016) The use of cash transfers for HIV prevention - are we there yet? Afr J AIDS Res 15(1):17-25.

  • Bassett IV, Wilson D, Taaffe J, et al. (2015) Financial incentives to improve progression through the HIV treatment cascade. Curr Opin HIV AIDS 10(6):451-63

  • Taaffe, J, Fraser-Hurt, N, Gorgens, M, Harimurti, P. (2014) A Comprehensive Review of Empirical and Modeled HIV Incidence Trends (1990-2012)  World Bank Policy Research Working Paper No. 7042

  • Wilson D, Taaffe J, Fraser-Hurt N, et al. (2014) The economics, financing and implementation of HIV treatment as prevention: what will it take to get there? Afr J AIDS Res 13(2):109-19.

  • McGary, CS, Cervasi, B, Chahroudi, A, Micci, L, Taaffe, J, et al.  (2014) Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques. J Virol 88(8):4533-42.

  • Klatt, N., Bosinger, S., Specht, A., Taaffe, J, et al. (2014) Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog 10(8):e1004345.

  • Taaffe JE, Bosinger SE, Del Prete GQ, et al. (2012) CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques. J Med Primatol (1):24-42.

  • Taaffe J, Chahroudi A, Engram J, et al. (2010) A five-year longitudinal analysis of sooty mangabeys naturally infected with simian immunodeficiency virus reveals a slow but progressive decline in CD4+ T-cell count whose magnitude is not predicted by viral load or immune activation. J Virol 84(11):5476-84.

  •  Riddick, NE., Hermann, EA, Loftin, LM, Elliott, ST, Wey, WC, Cervasi, B, Taaffe, J, et al. (2010)  A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog 6(8):e1001064.

  • Wang S, Parker C, Taaffe J, et al. (2008) Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 26(29-30):3626-33.

  • Wang S, Taaffe J, Parker C, et al. (2006) Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J Virol 80(23):11628-37.